4 minute read
Sep. 28, 2022

An Arginine-Targeting Covalent Strategy for KRAS(G12R)

compound 3

KRAS G12R mutant-selective covalent inhibitor privileged arginine-reactive functional group from previously disclosed KRAS inhibitors J. Am. Chem. Soc. University of California San Francisco, San Francisco, CA

drughunter.com
Drug Hunter Team
Reviewer:  
Loading...

twitterlinkedinemail

Other molecules you may be interested in